Listen to the Episode Below (00:41:15)
358: One Year After the IPO | Kim Drapkin, CFO, Jounce Therapeutics
Join us when CFO Kim Drapkin explains how she prioritizes the different aspects of her finance leadership role inside the biotech sector and reveals the different experiences that helped to prepare her to lead inside the entrepreneurial world of a mission-driven company. 2018 Milestones “We have our first clinical data coming out this year. So our…